Prediction model for prolonged fever in patients with Mycoplasma pneumoniae pneumonia: a retrospective study of 716 pediatric patients

被引:15
|
作者
Jang, Min Sik [1 ]
Kim, Bit Gyeol [1 ]
Kim, Jihye [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Pediat, Kangdong Sacred Heart Hosp, 150 Seongan Ro, Seoul 05355, South Korea
关键词
Mycoplasma pneumoniae pneumonia; Refractory; Prediction model; MACROLIDE RESISTANCE; CYTOKINES; THERAPY; SURVEILLANCE; INFECTION;
D O I
10.1186/s12890-021-01534-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To identify patients with Mycoplasma pneumoniae pneumonia (MPP) with a risk of prolonged fever while on macrolides. Methods A retrospective study was performed with 716 children admitted for MPP. Refractory MPP (RMPP-3) was defined as fever persisting for > 72 h without improvement in clinical and radiologic findings after macrolide antibiotics (RMPP-3) or when fever persisted for > 120 h (RMPP-5) without improvement in clinical and radiologic findings. Radiological data, laboratory data, and fever profiles were compared between the RMPP and non-RMPP groups. Fever profiles included the highest temperature, lowest temperature, and frequency of fever. Prediction models for RMPP were created using the logistic regression method and deep neural network. Their predictive values were compared using receiver operating characteristic curves. Results Overall, 716 patients were randomly divided into two groups: training and test cohorts for both RMPP-3 and RMPP-5. For the prediction of RMPP-3, a conventional logistic model with radiologic grouping showed increased sensitivity (63.3%) than the model using laboratory values. Adding laboratory values in the prediction model using radiologic grouping did not contribute to a meaningful increase in sensitivity (64.6%). For the prediction of RMPP-5, laboratory values or radiologic grouping showed lower sensitivities ranging from 12.9 to 16.1%. However, prediction models using predefined fever profiles showed significantly increased sensitivity for predicting RMPP-5, and neural network models using 12 sequential fever data showed a greatly increased sensitivity (64.5%). Conclusion RMPP-5 could not be effectively predicted using initial laboratory and radiologic data, which were previously reported to be predictive. Further studies using advanced mathematical models, based on large-sized easily accessible clinical data, are anticipated for predicting RMPP.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Risk of Mycoplasma pneumoniae-related hepatitis in MP pneumonia pediatric patients: a predictive model construction and assessment
    Bi, Yuna
    Ma, Yan
    Zhuo, Jinhua
    Zhang, Lili
    Yin, Liyan
    Sheng, Hongling
    Luan, Jie
    Li, Tao
    BMC PEDIATRICS, 2021, 21 (01)
  • [22] Elevated serum transaminases in patients with Mycoplasma pneumoniae pneumonia
    Cunha, BA
    Daxboeck, F
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (12) : 1051 - 1052
  • [23] Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients
    Xu, Weihan
    Wang, Heng
    Wen, Xiaohui
    Yang, Haiming
    Zhao, Shunying
    Liu, Jinrong
    ITALIAN JOURNAL OF PEDIATRICS, 2025, 51 (01)
  • [24] Mycoplasma pneumoniae pneumonia: CT features in 16 patients
    Inho Lee
    Tae Sung Kim
    Hye-Kyung Yoon
    European Radiology, 2006, 16 : 719 - 725
  • [25] Mycoplasma pneumoniae pneumonia:: CT features in 16 patients
    Lee, I
    Kim, TS
    Yoon, HK
    EUROPEAN RADIOLOGY, 2006, 16 (03) : 719 - 725
  • [26] Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
    Zhang, Yuqian
    Su, Chenglei
    Zhang, Yang
    Ding, Shuo
    Yan, Xianliang
    Zhang, Jianguo
    Tao, Zhimin
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [27] Azithromycin, erythromycin and doxycycline in the treatment of Mycoplasma pneumoniae pneumonia: A retrospective study
    Kuzman, I
    Schonwald, S
    Culig, J
    Oreskovic, K
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 211 - 214
  • [28] A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia
    Han, Li-ping
    Xiao, Han-yan
    Fang, Li-li
    MEDICINE, 2021, 100 (44)
  • [29] Retrospective analysis of Mycoplasma pneumoniae in pediatric fatal infection pneumonia in Guangzhou, South China
    Ou, Zhi-Ying
    Zhou, Rong
    Wang, Feng-Hua
    Lu, Jun-Peng
    Xia, Jian-Qing
    Xia, Hui-Min
    Zhang, Jian-Tao
    Gong, Si-Tang
    Deng, Li
    Wu, Zao-He
    Zeng, Qi-Yi
    CLINICAL PEDIATRICS, 2008, 47 (08) : 791 - 796
  • [30] Clarithromycin treatment of adult and pediatric patients with asthma with serologic evidence of mycoplasma pneumoniae infection - A retrospective study.
    Belenky, SN
    Skoner, DP
    Calhoun, WJ
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S131 - S131